FLUVASTATIN SODIUMER (Sandoz Inc)
Welcome to the PulseAid listing for the FLUVASTATIN SODIUM drug offered from Sandoz Inc. This HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | fluvastatin sodium |
SUBSTANCE NAME: | FLUVASTATIN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2015-10-16 |
END MARKETING DATE: | 0000-00-00 |
FLUVASTATIN SODIUM ER HUMAN PRESCRIPTION DRUG Details:
Item Description | FLUVASTATIN SODIUM ER from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 80(mg/1) |
START MARKETING DATE: | 2015-10-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-5370_c184692f-4afa-47b9-80d3-481fde50a4fa |
PRODUCT NDC: | 0781-5370 |
APPLICATION NUMBER: | NDA021192 |
Other FLUVASTATIN SODIUM Pharmaceutical Manufacturers / Labelers: